問卷

TPIDB > Principal Investigator

Principal Investigator


National Taiwan University Hospital (在職)

Division of Neurology

更新時間:2023-09-19

孫苑庭Sun, Yuan-Ting
  • Principal Investigator
  • Clinical Trial Experience (year) 12 years 9 個月

篩選

List

13Cases

2021-11-01 - 2027-09-01

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Recruiting5Sites

2016-10-20 - 2019-11-30

Phase III

A randomized, double-blind, double-dummy, parallel-group study comparing the efficacy and safety of ofatumumab versus teriflunomide in patients with relapsing multiple sclerosis
  • Condition/Disease

    relapsing multiple sclerosis

  • Test Drug

    Ofatumumab

Participate Sites
2Sites

Terminated1Sites

Study ended1Sites

2016-11-16 - 2020-01-31

Phase III

A multicenter, randomized, double-blind, placebo-controlled, phase 3 study to evaluate the efficacy and safety of SA237 as monotherapy in patients with neuromyelitis optica (NMO) and NMO spectrum disorder (NMOSD).
  • Condition/Disease

    neuromyelitis optica (NMO) and NMO spectrum disorder (NMOSD)

  • Test Drug

    SA237

Participate Sites
3Sites

Terminated2Sites

Study ended1Sites

1 2